Face Name matching and memory complaints in Parkinson’s disease
Objective: We aim to portray memory impairment in patients with Parkinson’s disease (PD) from an objective and subjective angle by using an innovative cross-modal associative…FDG-PET features of Lewy body dementia among patients with amnestic presentations typical for Alzheimer’s disease
Objective: To better understand the role of FDG-PET for identifying dementia with Lewy bodies (DLB) in the context of Alzheimer’s disease (AD)-like amnestic presentations, we…NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population
Objective: To validate NIMHANS Neuropsychological Battery for Elderly( NNB-E) and evaluate cognitive impairment in Parkinson's disease (PD) patients in comparison with healthy controls. Background: Cognitive…Cognition in parkinson disease: Tunisian clinical experience
Objective: In this study, we identified among Parkinson Disease patients those pre-disposed to cognitive impairment, and described their clinical profiles. Background: Parkinson disease (PD) is…Encoding, consolidation, and retrieval performance in memory tasks of MCI and n-MCI patients with Parkinson’s Disease.
Objective: Quantify and compare encoding, consolidation, and retrieval performance in verbal and visual memory tasks in MCI and Non-MCI Parkinson's disease. Background: Parkinson’s Disease (PD)…Distinct memory networks in Parkinson’s disease (PD) and Alzheimer’s disease (AD): Effects of APOE
Objective: As part of the Ontario Neurodegenerative Disease Research Initiative, we investigated group differences in functional connectivity within two distinct memory networks: posterior medial network…Identification and Documentation of Delirium in Parkinson’s Disease
Objective: To establish documentation, assessment and diagnosis practices in the medical notes of inpatients with Parkinson’s disease (PD) and delirium. Background: Delirium is a neuropsychiatric…Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology
Objective: To assess the non-inducing doses of scopolamine (SCL) on the memory function of Drosophila previously induced with Parkinson's disease phenotype. Background: A large body…A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease
Objective: To compare the serial position effects (SPE) between patients with Mild Cognitive Impairment (MCI) due to Parkinson’s disease (PD-MCI) and patients with MCI due…Mild Cognitive Impairment in Young Onset Parkinson Disease
Objective: To identify the prevalence of Parkinson disease mild cognitive impairment (PD-MCI) in a group of persons with young onset Parkinson disease (YOPD) consecutively referred…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.